Carregant...
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Significant advances have been made in developing novel therapeutics for cancer treatment, and targeted therapies have revolutionized the treatment of some cancers. Despite the promise, only about five percent of new cancer drugs are approved, and most fail due to lack of efficacy. The indication is...
Guardat en:
| Publicat a: | Cell |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583714/ https://ncbi.nlm.nih.gov/pubmed/26406370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2015.08.068 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|